Participating Faculty: Venous Thromboembolism After Total Hip Arthroplasty and Total Knee Arthroplasty

Venous Thromboembolism After Total Hip Arthroplasty and Total Knee Arthroplasty: Current and Future Perspectives

This supplement to The American Journal of Managed Care reviews the clinical and economic burden of venous thromboembolism (VTE), the prevalence of VTE after total hip arthroplasty and total knee arthroplasty, and evidence-based clinical practice guidelines for thromboprophylaxis. Anticoagulants available today and new oral agents currently in development are discussed. The benefits of the new oral anticoagulants are outlined, in terms of their potential for cost reduction.

Faculty

Onur Baser, PhD

Assistant Professor of Surgery

University of Michigan

President, STATinMED Research

The University of Michigan and STATinMED Research

Ann Arbor, Michigan

William D. Fisher, MD

Associate Professor

Interim Chief of Orthopaedic Surgery

Associate Professor

Department of Surgery

McGill University Health Centre

Montreal, Quebec, Canada

Louis M. Kwong, MD, FACS

Professor of Orthopaedic Surgery

Department of Orthopaedic Surgery

Harbor-UCLA Medical Center

Torrance, California

Geno Merli, MD, FACP, FHM, FSVM

Professor of Medicine

Jefferson Medical College

Director, Jefferson Center for Vascular Disease

Thomas Jefferson University Hospital

Philadelphia, Pennsylvania

Edith Nutescu, PharmD, FCCP

Clinical Professor

Antithrombosis Center/Center for Pharmacoeconomic Research

Department of Pharmacy Practice and Pharmacy Administration

College of Pharmacy

University of Illinois at Chicago

Chicago, Illinois

Acknowledgment

The authors would like to acknowledge Chris Thomas, who provided editorial support with funding from Ortho-McNeil Janssen Scientific Affairs, LLC.

Faculty Disclosures

These faculty members have disclosed the following relevant commercial financial relationships or affiliations in the past 12 months.

Onur Baser, PhD

, has nothing to disclose.

William D. Fisher, MD

Grants/honoraria:

Bayer

Portola

sanofi-aventis

Takeda

Lecturer:

Bayer

Boehringer Ingelheim

Johnson & Johnson

sanofi-aventis

Conference attendance:

Bayer

Johnson & Johnson

Louis M. Kwong, MD, FACS

Editorial board:

Journal of Surgical Orthopaedic Advances

Consultant/advisory board:

Zimmer

Honoraria:

GlaxoSmithKline

Grants:

Astellas

Bayer

GlaxoSmithKline

sanofi-aventis

Takeda

Geno Merli, MD, FACP, FHM, FSVM

Consultant/advisory board:

Bayer

Bristol-Myers Squibb

sanofi-aventis

Grants/Lecturer:

Bayer

Bristol-Myers Squibb

sanofi-aventis

Edith Nutescu, PharmD, FCCP

Grants/advisory board:

Ortho-McNeil Janssen Scientific Affairs, LLC

Venous Thromboembolism After Total Hip Arthroplasty and Total Knee Arthroplasty: Current and Future Perspectives

This supplement was made possible with the support of Ortho-McNeil Janssen Scientific Affairs, LLC and Johnson & Johnson Worldwide Market Access.

The contents of this supplement may include information regarding the use of products that may be inconsistent with or outside the approved labeling for these products in the United States. Physicians should note that the use of these products outside current approved labeling is considered experimental and are advised to consult prescribing information for these products.

Download PDF: Participating Faculty: Venous Thromboembolism After Total Hip Arthroplasty and Total Knee Arthroplasty